Leg Fluid Shift in Patients With Chronic Heart Failure & Obstructive or

Status Completed

Clinical Trial Summary

This study aims to investigate the influence of a potential leg fluid shift (LFS) in patients with chronic heart failure (CHF) and obstructive sleep apnea (OSA) or central sleep apnea (CSA).

Clinical Trial Description

Chronic heart failure (CHF) is a common disease in general western population with high levels of morbidity and mortality. Prospective risk factors need to be identified and investigated. The prevalence for sleep disordered breathing (SDB) in patients with CHF is higher compared to general population. Especially the occurence of CSA with its special breathing pattern of Cheyne-Stokes-Respiration (CSR) is frequent in CHF patients.The pathophysiology and relation inbetween sleep apnea (SA) and CHF isn´t completely identified yet. Multiple theories with different strategies try to explain the pathophysics and development of SA. Following one of these theories, patients with CHF often develop edema in lower body compartments. The idea is a possible influence of retrograde nocturnal LFS from lower body to upper body compartments which could induce pulmonal congestion. Therefore, an increased pulmonary capillary wedge pressure (PCWP) could irritate special pulmonal receptors resulting in CSR with periods of hyperventilation, related hypocapnia and central apnea events. OSA could be induced by fluid accumulation in the upper airway by retrograde fluid shift.

Patients with known CHF receive fluid measurements by b multi frequency bioimpedance analysis (mfBIA) the evening before and the morning after sleep is recorded using polygraphy (PG) or polysomnography (PSG) in hospital. Sleep results are analyzed by physicians using current guidelines of the American Academy of Sleep Medicine (AASM).

Capillary blood gas (CBG) samples are taken before and after sleep to examine the relation of fluid shift and blood gas changes.

A subgroup of the study group undergo additional investigation. Hemodynamic effects (e.g. reduced cardiac output (CO)) as a cause of a potential fluid shift is measured during wakefulness by using a tilting table. Hemodynamically relevant parameters are recorded non-invasively. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03092388
Study type	Interventional
Source	Heart and Diabetes Center North-Rhine Westfalia
Contact
Status	Completed
Phase	N/A
Start date	February 2015
Completion date	April 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01620554` - Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)	Phase 2
Not yet recruiting	`NCT01985347` - The SAD Study - SLEEP, ANXIETY & DEPRESSION Study A Prospective Cohort Study	N/A
Completed	`NCT01312558` - The Effect of the Mediterranean Diet on Obstructive Sleep Apnoea-Hypopnoea Syndrome: A Randomised Trial	N/A
Completed	`NCT02967536` - Investigating the Neuropathology of Obstructive Sleep Apnoea
Completed	`NCT02855515` - Drug-Induced Sleep Endoscopy for the Optimisation of Treatment of Patients With Obstruction Sleep Apnoea	N/A
Terminated	`NCT03127800` - Morphine in Moderate Obstructive Sleep Apnoea	Phase 3
Recruiting	`NCT04262986` - A Brief Lifestyle Modification Programme in Overweight Subjects With Obstructive Sleep Apnoea - Needs Assessment
Completed	`NCT03145129` - PAIR Study-PAP And IOP Relationship: Study 2
Completed	`NCT06376305` - EndoBarrier in Obstructive Sleep Apnoea Study	N/A
Completed	`NCT02713152` - Prevalence of Obstructive Sleep Apnoea in Glaucoma	N/A
Completed	`NCT01661712` - Continuous Transcutaneous Electrical Stimulation in Sleep Apnoea	N/A
Terminated	`NCT01530451` - Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients	Phase 3
Completed	`NCT02518633` - Obstructive Sleep Apnoea and Adipose Tissue Dysfunction	N/A
Completed	`NCT01557166` - Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea	Phase 3
Recruiting	`NCT01829854` - To Investigate the Incidence of Obstructive Sleep Apnoea in Patient Undergoing Open Heart Surgery	N/A
Completed	`NCT01619748` - Peripheral Vascular Function in Obstructive Sleep Apnoea	N/A
Completed	`NCT02417584` - Efficacy of PAP Therapy on Blood Pressure	N/A
Completed	`NCT04071860` - Developing a Non-contact Sleep Apnoea Detector, Suitable for Home Studies- The Safescan Study
Not yet recruiting	`NCT04607343` - Clinical Trial of a Rehabilitation Device Based on Electrostimulation for Obstructive Sleep Apnoea	N/A
Completed	`NCT01546792` - Lifestyle Intervention in Obstructive Sleep Apnoea	Phase 2/Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Leg Fluid Shift in Patients With Chronic Heart Failure and Obstructive or Central Sleep Apnea

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms